Atea Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Atea Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • Atea Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $12.2M, a 1.77% decline year-over-year.
  • Atea Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $49.6M, a 1.45% increase year-over-year.
  • Atea Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $49.4M, a 5.8% increase from 2022.
  • Atea Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $46.7M, a 17.9% increase from 2021.
  • Atea Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $39.6M, a 431% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $49.4M +$2.71M +5.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $46.7M +$7.1M +17.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $39.6M +$32.2M +431% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $7.46M +$6.83M +1095% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $624K +$210K +50.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $414K Jan 1, 2018 Dec 31, 2018 10-K 2021-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.